Correction Volume 15, Issue 9 pp 3891—3892
Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
- 1 Department of Obstetrics and Gynecology, Guizhou Provincial People's Hospital, Guiyan, Guizhou, 550002, China
- 2 Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China
- 3 Key Laboratory of Adult Stem Cell Transformation Research, Chinese Academy of Medical Sciences/Stem Cell and Tissue Engineering Research Center, Guizhou Medical University, Guiyang, 550004, China
- 4 Key Laboratory of Endemic and Ethnic Diseases and Key Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, Guiyang, 550004, China
- 5 Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA
- 6 Cancer Center, Daping Hospital and Research Institute of Surgery, The Third Military Medical University, Yuzhon, Chongqing, 40042, China
- 7 Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
- 8 Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400030, China
- 9 Department of Computer Science and Engineering, University of South Florida, Tampa, FL 33620, USA
- 10 Department of Bioengineering and Biotechnology, College of Chemical Engineering, Huaqiao University, Xiame, Fujian, 361021, China
- 11 Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China
Received: May 10, 2023 Accepted: May 11, 2023 Published: May 15, 2023
https://doi.org/10.18632/aging.204735How to Cite
Copyright: © 2023 Zi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The affiliation of Dr. Shu-Feng Zhou has been clarified. This work was started in Dr. Shu-Feng Zhou’s laboratory in 2013, when he was at the University of South Florida. However, he left that position in 2016 and was not affiliated with USF at the time of the article’s publication. His current affiliation is the College of Chemical Engineering, Huaqiao University, Xiamen 361021, China. The corrected authors affiliations are listed below.